证券代码：301559 证券简称：中集环科 公告编号：2025-032 中集安瑞环科技股份有限公司 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 一、 担保情况概述 为满足中集安瑞环科技股份有限公司（以下简称"公司"）控股子公司中集绿 建环保新材料（连云港）有限公司（以下简称"中集绿建连云港"）及中集环境服 务有限公司（以下简称"中集环服"）日常经营和业务发展需要，确保资金流畅， 公司于2025年11月24日召开第二届董事会第十二次会议以7票同意、0票反对、0 票弃权的表决结果审议通过了《关于公司2026年度为子公司提供担保额度预计的 议案》，在保证规范运营和风险可控的前提下，拟为上述子公司提供连带责任保 证担保。该议案尚需提交公司股东会审议。 2026年度，公司拟为中集绿建连云港向银行或其他金融机构申请的综合授信 额度提供不超过人民币2,000万元的连带责任保证担保； 2026年度，公司拟为中集环服向银行或其他金融机构申请的综合授信额度提 供不超过人民币2,000万元的连带责任保证担保。 上述担保额度期限自股东会审议通过之日起12个月，上述担保额度在有效期 ...

证券代码：301559 证券简称：中集环科 公告编号：2025-030 中集安瑞环科技股份有限公司 5、会议的召开方式：现场表决与网络投票相结合。 6、会议的股权登记日：2025 年 12 月 4 日 关于召开 2025 年第二次临时股东会的通知 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 一、召开会议的基本情况 1、股东会届次：2025 年第二次临时股东会 2、股东会的召集人：董事会 3、本次会议的召集、召开符合《中华人民共和国公司法》《深圳证券交易 所创业板股票上市规则》《深圳证券交易所上市公司自律监管指引第 2 号—创业 板上市公司规范运作》等法律、行政法规、部门规章、规范性文件及《公司章程》 的有关规定。 4、会议时间： （1）现场会议时间：2025 年 12 月 11 日 14:00 （2）网络投票时间：通过深圳证券交易所系统进行网络投票的具体时间为 2025 年 12 月 11 日 9:15-9:25，9:30-11:30，13:00-15:00；通过深圳证券交易所互 联网投票系统投票的具体时间为 2025 年 12 月 11 日 9:15 至 ...

证券代码：301559 证券简称：中集环科 公告编号：2025-029 中集安瑞环科技股份有限公司 第二届监事会第十二次会议决议公告 本公司及监事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 一、监事会会议召开情况 中集安瑞环科技股份有限公司（以下简称"公司"）第二届监事会第十二次会 议于 2025 年 11 月 24 日以现场结合通讯的方式召开。会议通知于 2025 年 11 月 17 日以书面方式发出。会议应出席监事 3 人，实际亲自出席监事 3 人，其中监 事秦钢先生、刘瑛女士以通讯表决方式出席。本次会议由公司监事会主席秦钢先 生主持。 本次监事会会议的召集、召开和表决程序符合《中华人民共和国公司法》等 有关法律法规、规范性文件和《中集安瑞环科技股份有限公司章程》的规定。 二、监事会会议审议情况 本次会议形成决议如下： （一）审议通过《关于 2026 年度日常关联交易额度预计的议案》 监事会认为：公司 2026 年预计发生的日常关联交易为公司正常经营所需， 交易价格遵循诚实信用、等价有偿、公平自愿、合理公允的基本原则，预计与关 联方发生的交易有利于公司主营业务的开 ...

证券代码：301559 证券简称：中集环科 公告编号：2025-028 中集安瑞环科技股份有限公司 第二届董事会第十二次会议决议公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 一、董事会会议召开情况 中集安瑞环科技股份有限公司（以下简称"公司"）第二届董事会第十二次会 议于 2025 年 11 月 24 日以通讯表决方式召开。会议通知于 2025 年 11 月 17 日以 书面方式发出。会议应出席董事 7 人，实际亲自出席董事 7 人。本次会议由公司 董事长杨晓虎先生主持，公司监事、部分高级管理人员列席了本次会议。 本次董事会会议的召集、召开和表决程序符合《中华人民共和国公司法》（以 下简称"《公司法》"）等有关法律法规、规范性文件和《中集安瑞环科技股份 有限公司章程》（以下简称"《公司章程》"）的规定。 二、董事会会议审议情况 本次会议形成决议如下： （一）审议通过《关于修订<公司章程>的议案》 为贯彻落实《公司法》《上市公司章程指引》及《深圳证券交易所创业板股 票上市规则》等相关法律法规、规范性文件的规定，根据中国证监会《关于新< 公司法>配套制度规 ...

Core Viewpoint - 中集安瑞环科技股份有限公司 has been recognized again as a "Manufacturing Single Champion Demonstration Enterprise," reinforcing its leading position in the liquid tank container sector and signaling sustained core competitiveness to the capital market [1][3]. Group 1: Company Recognition - 中集环科 successfully passed the review for the "Manufacturing Single Champion Demonstration Enterprise" title, highlighting its leadership in the liquid tank container market [1][3]. - The company is recognized as the first manufacturer of tank containers in China, with a global market share of one in every two tank containers produced [3]. Group 2: Evaluation Criteria - The "Manufacturing Single Champion" title is awarded based on stringent criteria, requiring companies to excel in specific niche markets, achieve international advanced production technology, and maintain a leading global market share [2]. - The review process occurs every three years, assessing companies on multiple dimensions, including market focus, technological leadership, and market share [2]. Group 3: Technological Innovation and Development - 中集环科's core competitiveness is supported by technological innovation, with a comprehensive product matrix covering standard, special, and gas tank containers [3]. - The company is actively expanding its service network and has implemented a "5G smart factory," recognized by the Ministry of Industry and Information Technology [3]. - Collaborations with Zhejiang University on AI projects focus on industrial AI models and digital twin technologies, enhancing the company's technological barriers [3]. Group 4: Future Outlook - The recent recognition is expected to inject strong momentum into 中集环科's high-quality development, aligning with global energy transition and logistics equipment upgrade demands [3]. - The company aims to continue leveraging technological innovation to maintain its global leadership and contribute to the advancement of China's manufacturing sector [3].

Group 1: Company Overview - The company specializes in the design, research and development, manufacturing, and sales of tank containers, being a global leader in liquid and liquefied gas logistics equipment manufacturing [1] - In 2025, the company faces challenges due to U.S. trade policy uncertainties and global geopolitical tensions, leading to a decline in tank container market demand and increased competition [1] - Despite challenges, the company maintains its leading market share in tank containers and continues to grow its medical equipment components business [1] Group 2: Product Details - The main products include a full range of tank containers, such as standard stainless steel liquid tank containers and special stainless steel liquid tank containers, tailored to customer needs [2] - Standard stainless steel liquid tank containers are primarily used for transporting bulk chemicals, while special containers are customized for specific requirements [2] - Carbon steel tank containers are used for the storage and transportation of gases and powders, offering advantages like high strength and corrosion resistance [2] Group 3: Market Outlook - The domestic market for tank containers is expected to grow, supported by the scale advantages of the chemical industry and policies promoting multimodal transport [3] - The government emphasizes the need for a modern logistics system to enhance efficiency and reduce costs, which benefits the tank container sector [3] Group 4: Financial Performance - In the first three quarters of 2025, the tank container business generated revenue of CNY 131,324.42 million, maintaining a strong market position [3] - The medical equipment components business also saw growth, with revenue of CNY 18,144.26 million in the same period, reflecting a year-on-year increase of 5.92% [4] Group 5: Future Strategy - The company aims to achieve sustainable growth through diversification and enhancing its risk resilience, focusing on expanding into high-end equipment and related fields [4] - A three-year shareholder dividend plan (2024-2026) has been established, ensuring that cash dividends will not be less than 50% of the distributable profits for the year [4] - In 2024, the company plans to distribute a cash dividend of CNY 4.4 per 10 shares, totaling CNY 264 million [4]

Group 1 - The article highlights the target price increases for several listed companies, with notable gains for CITIC Securities, Tongli Co., and Ailis, showing target price increases of 44.71%, 42.53%, and 38.88% respectively, across the securities, engineering machinery, and chemical pharmaceutical industries [1][2] - On November 6, the highest target prices and their respective target price increases were reported for CITIC Securities at 42.24 CNY, Tongli Co. at 31.00 CNY, and Ailis at 141.56 CNY [2] - Other companies with significant target price increases include Zhongchong Co. at 79.52 CNY (37.58%), Yongyi Co. at 15.78 CNY (35.45%), and BYD at 132.00 CNY (35.36%) [2] Group 2 - On November 6, the number of broker recommendations was reported, with notable mentions including Teruid at 30.30 CNY with 2 broker ratings, Jinghe Integrated at 32.99 CNY with 2 ratings, and Fuyao Glass at 67.51 CNY also with 2 ratings [3] - The rating for Taisheng Wind Power was upgraded from "Hold" to "Buy" by Tianfeng Securities on November 6 [4] - Three companies received initial coverage on November 6, including Daimai Co. with a "Buy" rating, Zhongji Huan Ke with an "Increase" rating, and Hengli Hydraulic with an "Increase" rating, all from Dongbei Securities [6]

Investment Rating - The report assigns a rating of "Accumulate" for the company [1]. Core Views - The company is experiencing short-term pressure on its performance, with new business segments showing steady growth [2]. - The leading position in the tank container business remains intact despite short-term challenges, supported by a solid order reserve [2]. - The company is actively pursuing digital transformation and future-oriented initiatives, enhancing its manufacturing capabilities [3]. - Profit forecasts for the company indicate a gradual recovery in net profit from 2025 to 2027 [3]. Financial Performance Summary - For the first three quarters of 2025, the company reported revenue of 1.75 billion yuan, a year-on-year decrease of 25.64%, and a net profit attributable to shareholders of 100 million yuan, down 44.73% [1]. - The third quarter alone saw revenue of 537 million yuan, a decline of 44.3% year-on-year, with a net profit of 36.96 million yuan, down 43.2% [1]. - The tank container business generated revenue of 1.313 billion yuan in the first three quarters, maintaining the largest market share [2]. - New orders signed in the first three quarters amounted to 1.613 billion yuan, with a backlog of 858 million yuan as of the end of September [2]. Business Segment Analysis - The tank container business remains the largest revenue contributor, despite facing demand pressures [2]. - Emerging businesses in medical equipment components and aftermarket services are showing steady growth, with revenues of 181 million yuan and 112 million yuan, respectively, representing year-on-year growth of 5.92% and 3.52% [2]. - The company has introduced innovative products, such as the first TDI railway tank container in China, addressing safety concerns in hazardous chemical transportation [2]. Future Outlook - The company is expected to achieve net profits of 183 million yuan, 262 million yuan, and 357 million yuan from 2025 to 2027, with corresponding PE ratios of 55, 39, and 28 times [3]. - The digital transformation efforts have been recognized at the national level, enhancing production efficiency and management precision [3].

Group 1: Company Overview - The company specializes in the design, research and development, manufacturing, and sales of tank containers, being a global leader in liquid and liquefied gas logistics equipment manufacturing [2] - In 2025, the company faces challenges due to U.S. trade policy uncertainties and global geopolitical tensions, leading to a decline in market demand for tank containers [2][3] - The company maintains its market share in tank containers while its medical device components business continues to grow [2][3] Group 2: Business Model and Market Applications - The company adopts a customer-centric market approach with a "sales-driven production, order-based procurement, and batch production" model [3] - Main products include a full range of tank containers, such as standard stainless steel liquid tanks and special stainless steel liquid tanks, catering to various industries [3] - The domestic market for tank containers is expected to grow, supported by the scale advantages of the chemical industry and policies promoting multimodal transport [3] Group 3: Financial Performance - In the first three quarters of 2025, the tank container business generated revenue of CNY 131,324.42 million, maintaining a leading market share [3] - The medical device components business reported revenue of CNY 18,144.26 million in the same period, reflecting a year-on-year increase of 5.92% [5] Group 4: Dividend Policy - The company emphasizes investor returns, planning to distribute at least 50% of its distributable profits as cash dividends annually from 2024 to 2026 [6] - In 2024, the company plans to distribute a cash dividend of CNY 4.4 per 10 shares, totaling CNY 264 million [6] Group 5: Future Development Directions - The company aims for sustainable growth through diversification, focusing on high-end equipment and expanding its medical equipment business [7][8] - Plans include enhancing capabilities in precision processing of non-ferrous metals and exploring new business opportunities in intelligent equipment [7][8] - The company seeks to transition from a leader in tank containers to a core technology platform for high-end equipment over the next three to five years [8]

Investment Rating - The investment rating for the company is "Accumulate" and is maintained [1] Core Insights - The company reported a significant decline in revenue and net profit for the first three quarters of 2025, with revenue at 1.75 billion yuan, down 25.64% year-on-year, and net profit at 100 million yuan, down 44.73% year-on-year. The decline is attributed to changes in global trade policies and a weak downstream chemical industry, leading to reduced demand in the tank container market and increased competition [4][5] - The company is positioned as a leader in the tank container manufacturing sector and is actively expanding into high-end medical equipment and intelligent equipment to create a second growth curve. The current low inventory levels in the tank container market suggest a potential demand rebound [6][7] - Revenue projections for 2025-2027 are estimated at 2.725 billion yuan, 3.998 billion yuan, and 4.916 billion yuan, respectively, with corresponding net profits of 169 million yuan, 308 million yuan, and 449 million yuan. The expected PE ratios are 61.10, 33.51, and 22.96 [7][8] Company Overview - The latest closing price of the company's stock is 17.18 yuan, with a total market capitalization of 10.3 billion yuan and a circulating market capitalization of 1.5 billion yuan. The company has a total share capital of 600 million shares, with 90 million shares in circulation [3] - The company has a debt-to-asset ratio of 13.7% and a PE ratio of 33.69 [3]